… Extramedullary extraosseous; EMM, Extramedullary multiple myeloma; H&E, Hematoxylin … MM, Multiple myeloma; MR, Magnetic resonance; NDMM, Newly diagnosed multiple myeloma; OS, … outcomes of newly diagnosed multiple myeloma patients presenting with …

… study in relapsed or refractory multiple myeloma patients who had received three … the care of patients with multiple myeloma and other disorders affecting plasma … occurred in 10%. Pharmacy Times: Multiple myeloma disproportionately affects Black patients. How …

… treatment goals for patients with multiple myeloma. Transcript What is the … For Newly Diagnosed, Transplant Ineligible Multiple Myeloma,” CURE; https:/… for-newly-diagnosed-transplant-ineligible-multiple-myeloma Transcript has been edited for …

… transplantation in patients with multiple myeloma making use of natural … allogeneic hematopoietic cell transplantation for multiple myeloma. Haematologica. 2019;104(2 … versus tandem autologous transplantation for multiple myeloma: comparison of long-term …

… of patients with newly diagnosed multiple myeloma who have the t(4 … patients with relapsed or refractory multiple myeloma who had received at least …

… strategies in relapsed/refractory multiple myeloma? Sidana: If approved, the … with relapsed/refractory multiple myeloma who may especially benefit from … in participants with newly diagnosed multiple myeloma as maintenance therapy following …

In this episode, experts outline key safety considerations and practical workflows for administering bispecific antibodies in clinical practice. Panelists emphasize that cytokine release syndrome and neurotoxicity associated with bispecific therapies are …

In this episode, experts discuss the reemergence of the antibody-drug conjugate belantamab and how it fits into a treatment landscape now dominated by bispecific antibodies and cellular therapies. Panelists explain that belantamab may offer an important …

… treat adults with newly diagnosed multiple myeloma who are ineligible for autologous … sensory neuropathy and musculoskeletal pain. Multiple myeloma is a blood cancer affecting … approved for eleven indications in multiple myeloma. June Lanoue, US president, …

… immune microenvironment among patients with multiple myeloma. Findings showed that the … , treatment-independent influence on multiple myeloma outcomes. Bhasin, professor in … microenvironment associated with outcomes in multiple myeloma. Nature Cancer. 2026; …